[go: up one dir, main page]

DE69934294D1 - Verwendung eines antimikrobiellen mittels so wie taurolidine oder taurultam zur herstellung eines arzneimittels zur behandlung einer nosokomialen mikrobiellen infektion - Google Patents

Verwendung eines antimikrobiellen mittels so wie taurolidine oder taurultam zur herstellung eines arzneimittels zur behandlung einer nosokomialen mikrobiellen infektion

Info

Publication number
DE69934294D1
DE69934294D1 DE69934294T DE69934294T DE69934294D1 DE 69934294 D1 DE69934294 D1 DE 69934294D1 DE 69934294 T DE69934294 T DE 69934294T DE 69934294 T DE69934294 T DE 69934294T DE 69934294 D1 DE69934294 D1 DE 69934294D1
Authority
DE
Germany
Prior art keywords
taurultam
taurolidine
medicament
manufacture
antimicrobial agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69934294T
Other languages
English (en)
Other versions
DE69934294T2 (de
Inventor
Rolf Pfirrmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Ed Geistlich Soehne AG fuer Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ed Geistlich Soehne AG fuer Chemische Industrie filed Critical Ed Geistlich Soehne AG fuer Chemische Industrie
Application granted granted Critical
Publication of DE69934294D1 publication Critical patent/DE69934294D1/de
Publication of DE69934294T2 publication Critical patent/DE69934294T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
DE69934294T 1998-01-08 1999-01-06 Verwendung eines antimikrobiellen mittels so wie taurolidine oder taurultam zur herstellung eines arzneimittels zur behandlung einer nosokomialen mikrobiellen infektion Expired - Lifetime DE69934294T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4063 1998-01-08
US09/004,063 US5972933A (en) 1998-01-08 1998-01-08 Method of treating microbial infections
PCT/GB1999/000028 WO1999034805A1 (en) 1998-01-08 1999-01-06 Use of antimicrobial agent such as taurolidine or taurultam in the manufacture of a medicament to treat a nosocomial microbial infection

Publications (2)

Publication Number Publication Date
DE69934294D1 true DE69934294D1 (de) 2007-01-18
DE69934294T2 DE69934294T2 (de) 2007-07-05

Family

ID=21708954

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69934294T Expired - Lifetime DE69934294T2 (de) 1998-01-08 1999-01-06 Verwendung eines antimikrobiellen mittels so wie taurolidine oder taurultam zur herstellung eines arzneimittels zur behandlung einer nosokomialen mikrobiellen infektion

Country Status (8)

Country Link
US (1) US5972933A (de)
EP (1) EP1044006B1 (de)
JP (2) JP2002500189A (de)
AU (1) AU757294B2 (de)
CA (1) CA2317748C (de)
DE (1) DE69934294T2 (de)
ES (1) ES2274614T3 (de)
WO (1) WO1999034805A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117868A (en) * 1998-09-16 2000-09-12 Ed. Geistlich Sohne Ag Fur Chemische Industrie Treatment of gastrointestinal ulcers or gastritis caused by microbial infection
CN100519525C (zh) * 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
DE60030770T2 (de) * 1999-12-06 2007-09-06 Rhode Island Hospital Verwendung von taurolidin oder taurultam zur herstellung eines medikaments zur behandlung von ovarialkarzinomen
US20020004502A1 (en) * 2000-01-05 2002-01-10 Redmond H. Paul Treatment of inflammatory bowel disease
EP1450814B1 (de) 2001-10-01 2016-11-30 Geistlich Pharma AG Verfahren zur hemmung von metastasen
US7240441B2 (en) * 2004-02-12 2007-07-10 Mccoy Ted Excavator thumb for use with excavator equipment
CA2636217C (en) * 2006-01-06 2014-02-25 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam
US20080008734A1 (en) * 2006-07-05 2008-01-10 Perrault James J Reduction of skin irritation caused by biomedical electrodes
US8548034B2 (en) * 2010-02-08 2013-10-01 Maxlinear, Inc. Methods and apparatus for intelligent power reduction in communications systems
EP2575783B1 (de) * 2010-06-01 2017-01-11 Geistlich Pharma AG Verfahren und zusammensetzungen für orale pharmazeutische therapie
US20130296223A1 (en) * 2012-03-30 2013-11-07 Sciclone Pharmaceuticals, Inc. Use of thymosin alpha for the treatment of sepsis
WO2014089226A1 (en) 2012-12-04 2014-06-12 The Board Of Trustees Of The University Of Illinois Antibacterial compounds targeting isoprenoid biosynthesis
US20180185378A1 (en) * 2017-01-05 2018-07-05 Cormedix Inc. Antimicrobial delivery system for the prevention and treatment of infections in the colon
EP3377067A4 (de) * 2015-10-07 2019-07-31 Cormedix Inc. Hautpenetrierende formulierung von taurolidin

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124285A (en) * 1964-10-06 1968-08-21 Geistlich Soehne Ag Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them
GB1557163A (en) * 1975-06-24 1979-12-05 Geistlich Soehne Ag Dental care preparations
US4107305A (en) * 1975-08-04 1978-08-15 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Treatment of endotoxaemia
US4002889A (en) * 1975-12-08 1977-01-11 Servo Corporation Of America Self-cleaning label for automatic object identification system
US4337251A (en) * 1979-05-09 1982-06-29 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of avoiding and removing adhesions
CA1190855A (en) * 1980-09-03 1985-07-23 Rolf W. Pfirrmann Treatment of osteitis
GB8328074D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compositions
GB8328073D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
GB8328111D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
DE3506288A1 (de) * 1984-09-06 1986-03-13 Johannes 7900 Ulm Reinmüller Vorrichtung zum einlegen in wunden und wundhoehlen
GB8424518D0 (en) * 1984-09-28 1984-11-07 Geistlich Sohne Af Fur Chemisc Chemical compounds
GB8514055D0 (en) * 1985-06-04 1985-07-10 Geistlich Soehne Ag Chemical substance
DE3533612A1 (de) * 1985-09-20 1987-04-02 Johannes Reinmueller Neuartige verwendung von taurolin
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
GB8813033D0 (en) * 1988-06-02 1988-07-06 Geistlich Soehne Ag Chemical compound
US5304540A (en) * 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
GB8827986D0 (en) * 1988-11-30 1989-01-05 Geistlich Soehne Ag Chemical product
IL96603A (en) * 1989-12-13 1998-02-08 Lilly Co Eli Antibacterial glycopeptide derivatives, process for their preparation and pharmaceutical compositions containing them
GB9005856D0 (en) * 1990-03-15 1990-05-09 Geistlich Soehne Ag Compositions
US5187082A (en) * 1990-08-16 1993-02-16 Eli Lilly And Company Process for producing A83850 antibiotics
DK0589893T3 (da) * 1991-04-15 1996-09-09 Applied Microbiology Inc Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori
EP0521225B1 (de) * 1991-07-04 1994-10-12 Hawe Neos Dental Dr. H. v. Weissenfluh SA Pharmazeutische Zubereitungen, Clavulansäure enthaltend, für die Behandlung der Periodontitis
GB9216155D0 (en) * 1992-07-30 1992-09-09 Geistlich Soehne Ag Treatment of dentoalveolar infections
US5650320A (en) * 1994-04-20 1997-07-22 University Of Alabama At Birmingham Research Foundation Lanthionine antibiotic compositions and methods
GB9600426D0 (en) * 1996-01-10 1996-03-13 Ed Geistlich Sohne A G Compositions
DK0876142T3 (da) * 1996-01-16 2001-11-19 Advanced Polymer Systems Inc Topisk tilførsel af lægemidler til den nedre mavetarmkanal

Also Published As

Publication number Publication date
CA2317748A1 (en) 1999-07-15
JP2010174032A (ja) 2010-08-12
US5972933A (en) 1999-10-26
ES2274614T3 (es) 2007-05-16
DE69934294T2 (de) 2007-07-05
EP1044006B1 (de) 2006-12-06
JP2002500189A (ja) 2002-01-08
WO1999034805A1 (en) 1999-07-15
CA2317748C (en) 2008-07-08
AU1884499A (en) 1999-07-26
EP1044006A1 (de) 2000-10-18
AU757294B2 (en) 2003-02-13
JP5469511B2 (ja) 2014-04-16

Similar Documents

Publication Publication Date Title
DE69934294D1 (de) Verwendung eines antimikrobiellen mittels so wie taurolidine oder taurultam zur herstellung eines arzneimittels zur behandlung einer nosokomialen mikrobiellen infektion
DE60035575D1 (de) Verwendubg von 3-hydroxy-3-methylglutaryl coenzym a reduktase inhibitoren zur herstellung eines medikaments zur behandlung der diabetischen neuropathie
DE69736183D1 (de) Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen
DE10085007T1 (de) Antiinfektionszusammensetzungen zur Behandlung von erkranktem Gewebe, wie Lippenherpes
DE60114580D1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
ATE164068T1 (de) Antiallergische zusammensetzung zur ophthalmischen oder nasalen anwendung
ATE487493T1 (de) Azolsäure-derivate, allein oder kombiniert, zur behandlung von diabetes und dyslipidaemien; und zur behandlung von malignen erkrankungen
ATE391487T1 (de) Zusammensetzung zur behandlung keratinischer fasern enthaltend ein assoziatives kationisches polyurethan und ein konditioniermittel
DE69902330D1 (de) Biomedizinische Vorrichtung mit antimikrobiellen Beschichtungen
ATE248599T1 (de) Verwendung von xenon zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von neurovergiftungen
DE60022916D1 (de) Reboxetin zur Behandlung von peripheren Neuropathien
DE60100625D1 (de) Verwndung von verbindungen mit 5-ht1a aktivität zur behandlung von krankheiten der äusseren retina
PT920421E (pt) Derivados de isoxazolina uteis como agentes antimicrobianos
CO5160266A1 (es) Nuevos agentes antibacterianos de isoxazolinona
NO20015464D0 (no) Attenuerte mikroorganismer for behandling av infeksjon
BR0014560B1 (pt) uso de uma composiÇço de tratamento de tecidos.
WO2006032904A3 (en) Medical devices and methods of making medical devices
BRPI0411534A (pt) derivados de lincomicina com atividade antimicrobiana
DE69910202D1 (de) EGR-1 zur Herstellung eines Medikamentes zur Behandlung von Wunden
DE59704912D1 (de) Antibakterielle Wirkung aufweisender Körper zur Verwendung als medizinisches oder chirurgisches Hilfsmittel
DE60318327D1 (de) Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe
ATE106183T1 (de) Biozide zusammensetzung und ihre verwendung.
DE60018200D1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
ATE314850T1 (de) Verwendung einer pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition